SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 102 400 KRW -1.54%
Market Cap: 8T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SK Biopharmaceuticals Co Ltd
Short-Term Debt Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Short-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Short-Term Debt
â‚©50B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Short-Term Debt
â‚©146.2B
CAGR 3-Years
33%
CAGR 5-Years
50%
CAGR 10-Years
19%
Hanmi Science Co Ltd
KRX:008930
Short-Term Debt
â‚©195.3B
CAGR 3-Years
53%
CAGR 5-Years
34%
CAGR 10-Years
13%
Hanmi Pharm Co Ltd
KRX:128940
Short-Term Debt
â‚©365.1B
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
21%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Short-Term Debt
â‚©22.9B
CAGR 3-Years
126%
CAGR 5-Years
55%
CAGR 10-Years
19%
C
Celltrion Pharm Inc
KOSDAQ:068760
Short-Term Debt
â‚©150B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
12%

See Also

What is SK Biopharmaceuticals Co Ltd's Short-Term Debt?
Short-Term Debt
50B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Short-Term Debt amounts to 50B KRW.

Back to Top